🇮🇳IN
Sign In
KP

KPL

NSE

Kwality Pharmaceuticals Ltd

₹3,528.40

-89.90(-2.48%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

KPL financial summary

For Mar 2026, Kwality Pharmaceuticals Ltd reported revenue of ₹503 crore, which grew 35.9% from the previous year. Net profit was ₹67 crore, which grew 67.5% year on year, on an operating margin of 24%. Earnings per share came in at ₹64.91. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹503 crore
Net profit₹67 crore
Operating margin24%
EPS₹64.91

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer